In summary, we demonstrated that Girdin could regulate the glycolysis of HCC cells via the PI3K/AKT/HIF-1α signaling pathway, which affects the sensitivity of tumor cells to radiotherapy. The gene discussed is AKT1; the disease is hepatocellular carcinoma.